Drug Profile
Research programme: transient receptor potential vanilloid 1 cation channel antagonists - AbbVie Laboratories
Alternative Names: A 889425; A-425619; A-780150; A-784168; ABT-443Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Developer AbbVie
- Class Indazoles; Pyridines; Small molecules; Urea compounds
- Mechanism of Action TRPV cation channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain